Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Lancet (London, England)
|
February 8, 2018
Atezolizumab and bladder cancer: facing a complex disease
Carlo Cattrini, Francesco Boccardo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2018
Androgen-Deprivation Therapy Is More Than Palliation in Oligometastatic Prostate Cancer
Carlo Cattrini, Elisa Zanardi, Francesco Boccardo
Cancer Treatment and Research Communications
|
October 22, 2020
Etoposide and topoisomerase II inhibition for aggressive prostate cancer: Data from a translational study
Carlo Cattrini, Matteo Capaia, Francesco Boccardo, et al.
Frontiers in Public Health
|
January 4, 2021
Medical Liability in Cancer Care During COVID-19 Pandemic: Heroes or Guilty?
Rosario Barranco, Carlo Messina, Alessandro Bonsignore, et al.
Therapeutic Advances in Urology
|
June 21, 2019
To switch or not to switch? A real-life experience using dexamethasone in combination with abiraterone
Elisa Zanardi, Davide Soldato, Maria Maddalena Latocca, et al.
European Journal of Clinical Investigation
|
December 31, 2020
Efficacy and safety of PD1/PDL1 blockade with platinum-based chemotherapy for extensive small cell lung cancer: A pooled analysis of randomized trials
Carlo Messina, Massimiliano Salati, Marco Messina, et al.
Anti-Cancer Drugs
|
July 30, 2019
Reduced dose of cabazitaxel in metastatic castration-resistant prostate cancer: from PROSELICA trial to the real life: A single institution experience
Giacomo Vallome, Carlo Cattrini, Carlo Messina, et al.
Cancers
|
August 23, 2020
Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer
Carlo Cattrini, Melissa Bersanelli, Maria Maddalena Latocca, et al.
Seminars in Oncology
|
November 10, 2020
Combination therapy in metastatic renal cell carcinoma: Back to the future?
Luigi Cerbone, Carlo Cattrini, Giacomo Vallome, et al.
International Journal of Cancer
|
August 17, 2022
Comments on "Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)"
Carlo Cattrini, Carlo Messina, Alessia Mennitto, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Lancet (London, England)
|
February 8, 2018
Atezolizumab and bladder cancer: facing a complex disease
Carlo Cattrini, Francesco Boccardo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2018
Androgen-Deprivation Therapy Is More Than Palliation in Oligometastatic Prostate Cancer
Carlo Cattrini, Elisa Zanardi, Francesco Boccardo
Cancer Treatment and Research Communications
|
October 22, 2020
Etoposide and topoisomerase II inhibition for aggressive prostate cancer: Data from a translational study
Carlo Cattrini, Matteo Capaia, Francesco Boccardo, et al.
Frontiers in Public Health
|
January 4, 2021
Medical Liability in Cancer Care During COVID-19 Pandemic: Heroes or Guilty?
Rosario Barranco, Carlo Messina, Alessandro Bonsignore, et al.
Therapeutic Advances in Urology
|
June 21, 2019
To switch or not to switch? A real-life experience using dexamethasone in combination with abiraterone
Elisa Zanardi, Davide Soldato, Maria Maddalena Latocca, et al.
European Journal of Clinical Investigation
|
December 31, 2020
Efficacy and safety of PD1/PDL1 blockade with platinum-based chemotherapy for extensive small cell lung cancer: A pooled analysis of randomized trials
Carlo Messina, Massimiliano Salati, Marco Messina, et al.
Anti-Cancer Drugs
|
July 30, 2019
Reduced dose of cabazitaxel in metastatic castration-resistant prostate cancer: from PROSELICA trial to the real life: A single institution experience
Giacomo Vallome, Carlo Cattrini, Carlo Messina, et al.
Cancers
|
August 23, 2020
Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer
Carlo Cattrini, Melissa Bersanelli, Maria Maddalena Latocca, et al.
Seminars in Oncology
|
November 10, 2020
Combination therapy in metastatic renal cell carcinoma: Back to the future?
Luigi Cerbone, Carlo Cattrini, Giacomo Vallome, et al.
International Journal of Cancer
|
August 17, 2022
Comments on "Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)"
Carlo Cattrini, Carlo Messina, Alessia Mennitto, et al.
Page
of 6